2 min read
Operationalizing Adaptive Design for FDA's One-Trial Era
Operationalizing Adaptive Design for FDA's One-Trial Era
October 20, 2026 : 11:00 AM ET
On February 18, 2026, the FDA...
1 min read
Biomarkers Part I: Basic Concepts of Biomarkers, Discovery and Identification
|
Join Veristat at the MassBio Forum on March 3, 2015 from 8:00 AM to 10:00 AM to participate in an informational session entitled, "Biomarkers Part I: Basic Concepts of Biomarkers, Discovery and Identification."
John P. Balser, PhD, President, Founder and Chief Biostatistician, Veristat, LLC will be moderating the event.
Location: MassBio, 300 Technology Square, 8th Floor, Cambridge, MA
Event Information:
Click for event information and registration
|
|
This first of two Forums prepared specifically for MassBio members will present the history of biomarker discovery, review why biomarkers are important to clinical research and explore their basic concepts. Plan to attend to receive an in-depth look into the biomarker discovery process and illustrations of their many classes. You will also learn how biomarker R&D is a modular, highly interdependent process that requires a systems-based approach.
Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial.
STAY CONNECTED
|